Key result
Open access echocardiography and biomarker screening can help general practitioners detect systolic and diastolic dysfunction and separate cardiac from non-cardiac causes of dyspnea.
Why the study?
Does screening with plasma NT-pro BNP or BNP and open access echocardiography improve the detection of systolic and diastolic heart failure in patients with dyspnea?
Does screening with plasma NT-pro BNP or BNP and open access echocardiography improve the detection of systolic and diastolic heart failure in patients with dyspnea?
Initial screening with BNP/NT-proBNP and open access echocardiography are effective strategies for general practitioners to differentiate cardiac from non-cardiac causes of dyspnea.
The incidence and prevalence of dyspnea increases with age. Frequently, for the general practitioner with his limited diagnostic facilities, it is impossible to separate dyspnea from cardiac causes and non-cardiac causes. Without cardiac imaging it is also impossible to separate systolic dysfunction from diastolic dysfunction. After a thorough physical examination, initial screening of systolic and diastolic heart failure can be done by measurement of plasma NT-pro BNP or plasma BNP. Additionally a Chest X-Ray or ECG can be performed. To improve diagnostic performance an open access echocardiographic service can be initiated. Recent studies showed, that open access echocardiography can easily detect systolic and diastolic dysfunction in the community and can separate cardiac from non-cardiac dyspnea.
No takes yet. Share an insight, caveat, or question.
Bolt et al. (2009) conducted a review in Heart failure and dyspnea. Open access echocardiography and biomarker screening (NT-pro BNP/BNP) was evaluated. Open access echocardiography and biomarker screening can help general practitioners detect systolic and diastolic dysfunction and separate cardiac from non-cardiac causes of dyspnea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: